Jazz Pharmaceuticals (JAZZ)
(Real Time Quote from BATS)
$110.69 USD
+0.84 (0.77%)
Updated May 7, 2024 02:28 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Brokerage Reports
0 items in cart
Jazz Pharmaceuticals PLC [JAZZ]
Reports for Purchase
Showing records 121 - 140 ( 246 total )
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
3Q18 Results; Taking Stock of and Reiterating our Neutral Thesis; M-A and Xyrem Life Cycle Remain Wildcards
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
2Q18 Results; Vyxeos Challenge a Reminder That M-A Is No Free Lunch; Reiterate Neutral but Raise to $167
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O